In this study, we examined the causal role of the BDNF-TrkB pathway in the ELS-induced cognitive deficits and evaluated the therapeutic effects of 7,8-DHF, the TrkB agonist attracting widespread attention for its cognition-enhancing effects. The gene discussed is NTRK2; the disease is Cognitive impairment.